Connect With the Drug Developers Scaling Safe & Durable Cell Therapies for Autoimmune Conditions
The 4th Cell Therapy for Autoimmune Disease Summit provides a unique opportunity to connect with the biotech, pharma, academic, and clinical leaders advancing the next generation of autoimmune cell therapies.
Whether you offer manufacturing solutions, CRO services, automation platforms, translational research capabilities, or specialized analytical tools, this is your opportunity to position your organization alongside the teams driving innovation and evaluating new technologies, services, and strategic partnerships.
As the field moves beyond early proof-of-concept studies and into broader clinical development, demand for specialist expertise continues to grow. Developers are seeking support across manufacturing scale-up, CMC strategy, immune monitoring, analytical testing, patient recruitment, clinical operations, site activation, and commercialization as they work to bring autoimmune cell therapies to larger patient populations.
Why Prioritize Partnering With This Summit?
Reach Decision-Makers at a Critical Inflection Point
2026 is the year autoimmune cell therapy moves beyond anecdotal success stories into a data-driven commercial opportunity. As developers evaluate new clinical datasets across multiple modalities and prepare for the next phase of development, they are actively seeking expertise in clinical operations, analytics, manufacturing scale-up, and translational technologies.
Access the Full Autoimmune Cell Therapy Ecosystem in One Place
As the only meeting dedicated to autoimmune cell therapy, this summit brings together leaders advancing across cell types from autologous to allogeneic and in vivo approaches. For solution and service providers, this creates a unique opportunity to engage a diverse audience of stakeholders tackling the challenges of scaling global clinical trials, patient screening, and delivering robust packages under increased scrutiny in safety, durability, and efficacy data.
Position Your Organization Ahead of Growing Outsourcing Demand
With increasing regulatory uncertainty and growing pressure to scale programs cost-effectively, developers are looking for partners who can help accelerate progress programs from translational studies to late phase trials and beyond. Whether supporting preclinical research, clinical development, or manufacturing strategy, partnering with this summit allows you to establish your organization as a trusted partner before demand across the sector accelerates.
What to Expect?
Meet Qualified Prospects
Connect directly with biotech and pharma teams actively seeking partners to support manufacturing, clinical development, translational research, and commercialization activities.
Demonstrate Your Expertise
Showcase your capabilities through speaking opportunities, panel discussions, roundtables, and exhibition presence to position your organization as a trusted partner.
Support a Scaling Industry
Engage with companies preparing for larger patient populations, manufacturing expansion, and increasingly complex development programs.
Build Strategic Partnerships
Meet scientific, clinical, operational, and business leaders responsible for outsourcing decisions across the development lifecycle.
Generate Actionable Market Intelligence
Understand future customer needs by hearing directly from developers discussing manufacturing bottlenecks, clinical trial challenges, and emerging technology requirements.
Increase Brand Visibility
Elevate your profile through website exposure, event branding, thought leadership opportunities, and face-to-face networking.
What Services Are Biopharma Experts Seeking?
Our attendees from biotech, pharma, academia, and clinical research organizations are looking for service and solution providers with expertise across the cell therapy development lifecycle, including manufacturing, analytics, clinical operations, and commercialization support.
Areas of particular interest include:
Cell Therapy Manufacturing & CDMO Services
In Vivo Engineering & LNP Development
Clinical CRO & Trial Operations
Patient Recruitment & Site Engagement
Apheresis & Cell Collection Services
Translational Research & Preclinical Models
Biomarker, Assay & Immune Monitoring Platforms
Automation, Supply Chain & Logistics Solutions
Hear What Our Past Sponsors & Attendees Have to Say
Relevant talks, recaps of recent clinical data, and discussions about some of the most pressing topics in the field.
Senior Engineer, TG Therapeutics
2025 Sponsor
A lot of new fascinating efficacy data in autoimmune diseases detailing the progress the industry has made. This also allowed for transparent panel talks and Q&A sessions.
Scientist, Thermo Fisher Scientific
2025 Sponsor
The collaborative environment across company representatives. The presentations were more like discussions.
Associate Director, Competitive Intelligence & Cell Therapy, Bristol Myers Squibb
2025 Delegate
Cell therapies for autoimmune diseases have entered a new phase in 2026 with promising clinical data and recent approvals across multiple modalities. It is an exciting time to focus on autoimmune disease.
Chief Business Development Officer, Immuthera / PolTREG
2026 Speaker
Audience Composition
Who You Can Build Partnerships With:
Available Inventory
The 4th Cell Therapy for Autoimmune Disease Summit offers a range of sponsorship opportunities designed to maximize visibility, generate qualified leads, and position your company as a key contributor to the advancement of autoimmune cell therapies.
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
Jessica Alarms
Partnerships Director
4th Cell Therapy for Autoimmune Disease Summit